Prism Medico & Pharmacy’s promoter Ajooni Biotech has sold 52350 equity shares or 0.86% of the company through open market sale on September 19, 2018. The promoter entity's stake has decreased from 1252442 equity shares or 20.65% to 1200092 equity shares or 19.79%.
Prism Medico and Pharmacy is engaged in trading in goods and commodities.